|
|
|
Registry of biomedical companies:
[3] [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Y] [Z] 460 active entries
203 2nd Floor, Morya landmark-I, Off Link Road, An
Mumbai,400053
India
Phone: +91-22-42172317
Fax: +91-22 6694 1179
E-Mail:
This e-mail address is being protected from spam bots, you need JavaScript enabled to view it
Please notice: This entry hasn't been updated by the submitting company for more than 2 years. It could be possible that this company doesn't longer exists.
Description:
Vedic Lifesciences, a Phase II/III CRO, also undertakes project management of Pre-Clinical Development Services for Pharma, Biotech and Phytopharma. We also offer the Indian advantage of cost, timeline & quality. We have an in-house team for Medical Affairs, Regulatory, Project Management and Data Management and have completed 34 trials and 7 trials are on-going for approvals in various categories. Our therapeutic expertise includes: Orthopedics, Diabetes, Andrology/Urology, Cardiovascular Disorders, HIV/AIDS, Endocrinology, Lifestyle Disorders, Metabolic Disorders, Dermatology, Respiratory Disorders etc.
Recently, we have conducted a Disease Prevalence Survey in all zones of India for therapeutic areas like Orthopedics, Oncology, Diabetes, Endocrinology, Dermatology, Neurology, Andrology/Urology, HIV/AIDS and Gynecology and created a good database of doctors, trained and helped them to become researcher (Investigator). We have also created a database of Primary health centers and created awareness about Clinical research to get their support for Patients Volunteers recruitment, which is very vital for the Cancer Studies. Since, Cancer is very dangerous for human life and spreading at fast pace in India, we are concentrating more on that. While working on Cancer, we have recognized problems in conducting Cancer studies and developed a model for fast Patient Volunteers recruitment. You can find the literature at www.vediclifesciences.blogspot.com.
Selected Categories:
Last update of this entry: August 10, 2009
|